Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assay
about
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT.Precision and linearity targets for validation of an IFNgamma ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides.Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy.Broad and cross-clade CD4+ T-cell responses elicited by a DNA vaccine encoding highly conserved and promiscuous HIV-1 M-group consensus peptides.Validation of an IFNγ/IL2 FluoroSpot assay for clinical trial monitoring.Defining ELISpot cut-offs from unreplicated test and control wells.ELISpot for measuring human immune responses to vaccines.Immune response and survival of refractory cancer patients who received TGF-β2 antisense/GM-CSF gene modified autologous tumor cell (TAG) vaccine.Risk factors for increased immune reconstitution in response to Mycobacterium tuberculosis antigens in tuberculosis HIV-infected, antiretroviral-naïve patients.Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathiesWhat Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM.
P2860
Q30444086-87BB3509-00D6-4691-9ECD-6B64EA605240Q30484153-F902B726-008D-487C-A095-85E7D0CBFB4DQ33325811-E54B89CB-7252-4E0B-ADB4-72A98161F03BQ33640197-ED42ED7C-ED80-4D1F-A7FB-14C03656358CQ34428561-6C5A5F1E-0B0F-4723-9735-5E7FFA715C66Q34530756-A72DD379-EF6B-41E2-A4ED-49F5F0FC77C7Q36852775-B836C3AB-240F-4370-943A-17FA8C026070Q37857243-9D86DFF9-9FC1-4145-B4AF-9A1C20E89C70Q39456127-F0A40325-1BF9-41DA-880C-B27944638033Q40057121-14A06B97-AFEF-4B08-A7A4-F306B2E991C6Q42073430-290E5172-A753-4568-829E-C57F93826088Q47561102-571334D5-0FBF-4EF1-BF04-78E47F84B691
P2860
Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assay
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Evaluation of the interlaborat ...... enzyme-linked immunospot assay
@ast
Evaluation of the interlaborat ...... enzyme-linked immunospot assay
@en
Evaluation of the interlaborat ...... enzyme-linked immunospot assay
@nl
type
label
Evaluation of the interlaborat ...... enzyme-linked immunospot assay
@ast
Evaluation of the interlaborat ...... enzyme-linked immunospot assay
@en
Evaluation of the interlaborat ...... enzyme-linked immunospot assay
@nl
prefLabel
Evaluation of the interlaborat ...... enzyme-linked immunospot assay
@ast
Evaluation of the interlaborat ...... enzyme-linked immunospot assay
@en
Evaluation of the interlaborat ...... enzyme-linked immunospot assay
@nl
P2093
P2860
P356
P1476
Evaluation of the interlaborat ...... enzyme-linked immunospot assay
@en
P2093
ANRS ELISpot Standardization Group
H Gahery-Segard
J-P Aboulker
P2860
P304
P356
10.1128/CVI.00387-05
P577
2006-06-01T00:00:00Z